drugset / Trial / NCT00161473

Alzheimer's in Long-Term Care--Treatment for Agitation

NCT00161473

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to see if a medication called prazosin is useful in the treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other types of dementia in late life.

Timeline

Start
2001-01
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prazosin Unknown 6 mg

Indications